Taro Pharmaceutical IndusTARO
13F holders, Q2 2024 (June 30)16holders −77
6new positions
83sold out
$42.99avg. 13F price*
At the end of Q2 2024, 16 institutions reported holding Taro Pharmaceutical Indus (TARO) in their 13F filings, down 77 from Q1 2024. 6 opened new positions and 83 sold out. The largest holders were Krensavage Asset Management, LLC ($28.0M), Analyst IMS Investment Management Services Ltd. ($583K) and Rhumbline Advisers ($542K).
- Company
- Taro Pharmaceutical Indus
- CUSIP
- M8737E108
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $17K |
| Exits | 83 | $170.4M |
All 13F filers, Q1 2024 → Q2 2024: 5,785 shares bought and 4,019,891 shares sold, net −4,014,106 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 16 holders
| Krensavage Asset Management, LLC | 12.83% | Add +0.3% | 650,089 | $28.0M |
| Analyst IMS Investment Management Services Ltd. | 0.02% | No change | 13,557 | $583K |
| Rhumbline Advisers | 0.00% | Add +31.4% | 12,625 | $542K |
| LRI Investments, LLC | 0.01% | No change | 2,000 | $86K |
| Gladius Capital Management LP | 0.03% | Reduce -5.6% | 761 | $33K |
| Osaic Holdings, Inc. | 0.00% | New | 199 | $9K |
| Lindbrook Capital, LLC | 0.00% | No change | 142 | $6K |
| Farther Finance Advisors, LLC | 0.00% | Add +1700.0% | 126 | $5K |
| MassMutual Private Wealth & Trust, FSB | 0.00% | New | 76 | $3K |
| Cwm, LLC | 0.00% | Add +273.3% | 56 | $2K |
| Blue Trust, Inc. | 0.00% | New | 44 | $2K |
| Red Tortoise LLC | 0.00% | New | 40 | $2K |
| Covestor Ltd | 0.00% | Reduce -10.3% | 26 | $1K |
| Parallel Advisors, LLC | 0.00% | New | 19 | $816 |
| CIBC Private Wealth Group LLC | 0.00% | New | 8 | $344 |
| Cornerstone Planning Group LLC | 0.00% | No change | 94 | $0 |
"% of holder's portfolio" is TARO's weight in each manager's 13F, not the share of Taro Pharmaceutical Indus the manager owns.